Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

81. Hepatitis | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/hepatitis

82. Gallbladder Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/gallbladder-diseases

83. Hepatitis B | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/hepatitis-b

84. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Rheumatoid arthritis OA and RA: 200- 300 mg divided 2- 4x/day; max 300 mg/day Renal impairment, liver … sustained-release product, 75 mg 1- 2/day Severe renal impairment: (CrCL less than 15 mL/min), liver … (CrCl l<25 mL/min) max 100 mg/day; Geriatric(> 75 yrs) initiate with doses of 75-150 mg/day; Liver … longer than 10 days Juvenile RA: 10 mg/kg/day given in 2 divided doses; Renal impairment and liver … Avoid use in patients with severe liver dysfunction. Appendix B.

85. Disposition of Comments: Comparative Effectiveness Review No. 237_Integrating Palliative Care in Ambulatory Care of Noncancer Serious Illness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-237-integrating-palliative-care-disposition-comments.pdf
    February 11, 2021 - I feel lack of specific review on liver diseases is a significant omission. … would like to bring to your attention is “Benefit of Early Palliative Care Intervention in End-Stage Liver … Disease Patients Awaiting Liver Transplantation” by Alexandra Baumann.

86. Omega-3-Maternity Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
    May 18, 2015 - Source: www.effectivehealthcare.ahrq.gov Published online: May 18, 2015 24 #39 cod AND ('liver … '/exp OR liver) AND oil* OR codliver AND oil* OR marine AND oil* OR marine AND fat #40 'salmon'/exp … 63 (walnut$ or butternut$ or soybean$ or pumpkin seed$).mp. 64 (fish adj2 oil$).mp. 65 (cod liver … butternut*or soybean* or "pumpkin seed" or pumpkinseed*:ti,ab,kw #12 "cod liver … and (oil or oils) ) OR walnut* or butternut*or soybean* or "pumpkin seed" or pumpkinseed* OR "cod liver

87. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
    September 02, 2016 - mackerel OR herring OR tuna OR halibut OR seaweed OR anchovy OR anchovies OR sardine OR sardines OR cod liver … (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp. … (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp. … menhaden OR fish AND oil*) OR (walnut* OR butternut* OR soybean* OR pumpkin AND seed*) OR (cod AND liver … menhaden OR fish AND oil*) OR (walnut* OR butternut* OR soybean* OR pumpkin AND seed*) OR (cod AND liver

88. Vte-Prophyalaxis Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - and safety of pharmacologic and mechanical strategies to prevent VTE in hospitalized patients with liver … Burns (KQ 3) • Thrombocytopenia and/ or prolonged international normalized ratio secondary to liver … We did not identify any studies among patients with liver failure. … Patients With Liver Disease We found no studies that directly addressed the comparative effectiveness … and safety of pharmacologic strategies for VTE prevention in patients with liver disease.

89. What is the comparative effectiveness of various local treatments for (1) unresectable liver metastases and (2) unresectable, localized hepatocellular carcinoma (HCC)? Does the comparative effectiveness vary when lesions are unresectable… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresec

90. Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
    November 01, 2016 - ��Elderly people with liver problems should talk with their health care professional before taking … increase the risk of suicidal thoughts and behaviors in young adults (ages 18 to 24). �� It can cause liver

91. Jaundice | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/jaundice

92. Alpha-1 Antitrypsin Deficiency | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/alpha-1-antitrypsin-deficiency

93. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
    June 01, 2016 - These patients include: »» children who have IH in functionally sensitive areas (e.g., eyes, liver,

94. Gallbladder Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/gallbladder-cancer

95. Colorectal-Cancer-Protocol_130520 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - useful for imaging the rectum (because the rectum is held relatively fixed by surrounding tissues) or liver … In the setting of colorectal cancer staging, TUS is mainly used to image the liver for the potential … appropriate • None reported Usually not indicated • PET-CT not routinely indicated Suspected liver … of the abdomen and pelvis o For rectal cancer: endoscopic ultrasound versus MRI o For suspected liver … American College of Radiology Appropriateness Criteria®: Suspected Liver Metastases [Online Publication

96. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Population: Elderly, General population/Adults Preexisting conditions: obesity, CVD, diabetes, CKD, liver … 3924 Population: Elderly, General population/Adults Preexisting conditions: CVD, diabetes, CKD, liver … Population: Elderly, General population/Adults Preexisting conditions: COPD, CVD, diabetes, CKD, liver … Population: Elderly, General population/Adults Preexisting conditions: COPD, CVD, diabetes, CKD, liver … Population: Elderly, General population/Adults Preexisting conditions: COPD, CVD, diabetes, CKD, liver

97. CARDIOVASCULAR (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - No patient permanently stopped lomitapide because of liver abnormalities. … ) to an emerging apo-B molecule, which then forms a chylomicron in the intestine or VLDL in the liver … During the trial, researchers reported that no patient permanently stopped lomitapide because of liver … ., statins) and invasive, resource-intensive treatments such as apheresis and, in rare instances, liver … representing research perspective.81 Another research expert commented that liver function testing

98. - (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
    January 01, 2009 - Glutamate-Oxaloacetate Transaminase: Liver enzyme whose levels are increased during liver damage. … Glutamate-Pyruvate Transaminase: Liver enzyme whose levels are increased during liver damage. … Hypoalbuminemia: A condition where levels of albumin, which is produced by the liver, are low in the … Usually indicative of liver damage. … Liver Cirrhosis: A condition resulting from chronic disease of the liver where normal tissue has been

99. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - vs placebo reported more nausea / vomiting, respiratory infection, abdominal pain, and abnormal liver … Liver enzyme changes were common. … Liver enzyme changes were common. Mease, 20118 RCT CASPAR Anti-TNF: Abatacept. … Common adverse events include: nausea/ vomiting, respiratory infection, abdominal pain, abnormal liver

100. Topic Brief: Updating Pharmacotherapy for Adults with Alcohol Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
     September 30, 2022 - consumption linked to numerous acute and chronic conditions, including heart disease, diabetes mellitus, liver … of Baclofen,41 Nalmefene,33 and Quetiapine34 among adults with AUD and co-occurring alcohol-related liver … Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver … Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent … effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver